Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 10, 2023 Filed Apr 12, 2023 20:08 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
SaleCommon Stock | 10,000 | $99.56 | $995,600.00 |
DisclosureSEC source: 0001209191-23-024073 · doc4.xml · nonDerivative · entry 2 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 425,896 F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 17, 2022. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:08 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $67.81 | $678,100.00 |
DisclosureSEC source: 0001209191-23-024073 · doc4.xml · nonDerivative · entry 1 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 435,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 17, 2022. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 23:00 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 10,000 | $0.00 Strike: $67.81 | $0.00 |
DisclosureSEC source: 0001209191-23-023942 · doc4.xml · derivative · entry 6 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,130 Underlying: Common Stock · 10,000 shares Expires 2023-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 17, 2022. F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 23:00 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
SaleCommon Stock | 10,000 | $96.13 | $961,300.00 |
DisclosureSEC source: 0001209191-23-023942 · doc4.xml · nonDerivative · entry 2 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 425,896 F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 17, 2022. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 23:00 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $67.81 | $678,100.00 |
DisclosureSEC source: 0001209191-23-023942 · doc4.xml · nonDerivative · entry 1 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 435,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 17, 2022. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 23:59 UTC |
LAWLIS V BRYANDirector
|
Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 8,500 | $0.00 Strike: $67.81 | $0.00 |
DisclosureSEC source: 0001209191-23-023062 · doc4.xml · derivative · entry 3 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,500 shares Expires 2023-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 29, 2022. F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 23:59 UTC |
LAWLIS V BRYANDirector
|
SaleCommon Stock | 8,500 | $97.09 | $825,265.00 |
DisclosureSEC source: 0001209191-23-023062 · doc4.xml · nonDerivative · entry 2 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,950 F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 29, 2022. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 23:59 UTC |
LAWLIS V BRYANDirector
|
Exercise / conversionCommon Stock | 8,500 | $67.81 | $576,385.00 |
DisclosureSEC source: 0001209191-23-023062 · doc4.xml · nonDerivative · entry 1 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 29, 2022. Read SEC document |
| March 16, 2023 Filed Mar 18, 2023 01:42 UTC |
Mueller BrianEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 3,973 | $93.41 | $371,117.93 |
DisclosureSEC source: 0001567619-23-005297 · doc1.xml · nonDerivative · entry 3 Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,585 Read SEC document |
| March 16, 2023 Filed Mar 18, 2023 01:37 UTC |
FUCHS HENRY JPresident, Worldwide R&D
|
Tax withholdingCommon Stock | 36,000 | $93.41 | $3,362,760.00 |
DisclosureSEC source: 0001567619-23-005295 · doc1.xml · nonDerivative · entry 3 FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,187 Read SEC document |
| March 16, 2023 Filed Mar 18, 2023 01:31 UTC |
Davis George EricEVP, Chief Legal Officer
|
Tax withholdingCommon Stock | 19,957 | $93.41 | $1,864,183.37 |
DisclosureSEC source: 0001567619-23-005292 · doc1.xml · nonDerivative · entry 3 Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,367 Read SEC document |
| March 16, 2023 Filed Mar 18, 2023 01:16 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 20,510 | $93.41 | $1,915,839.10 |
DisclosureSEC source: 0001567619-23-005283 · doc1.xml · nonDerivative · entry 3 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,486 Read SEC document |
| March 16, 2023 Filed Mar 18, 2023 01:22 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 88,623 | $93.41 | $8,278,274.43 |
DisclosureSEC source: 0001567619-23-005285 · doc1.xml · nonDerivative · entry 3 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,896 Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:47 UTC |
Guyer Charles GregEVP, Chief Technical Officer
|
GrantStock Option (Right to buy Common Stock) · Derivative | 20,320 | $0.00 Strike: $87.74 | $0.00 |
DisclosureSEC source: 0001567619-23-005299 · doc1.xml · derivative · entry 3 Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,320 Underlying: Common Stock · 20,320 shares Expires 2033-03-14 F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:47 UTC |
Guyer Charles GregEVP, Chief Technical Officer
|
Tax withholdingCommon Stock | 1,856 | $87.74 | $162,845.44 |
DisclosureSEC source: 0001567619-23-005299 · doc1.xml · nonDerivative · entry 2 Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,464 Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:47 UTC |
Guyer Charles GregEVP, Chief Technical Officer
|
GrantCommon Stock | 8,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-005299 · doc1.xml · nonDerivative · entry 1 Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,320 F1 · price: Restricted stock units granted on March 15, 2023. Price not applicable. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:42 UTC |
Mueller BrianEVP, Chief Financial Officer
|
GrantStock Option (Right to buy Common Stock) · Derivative | 21,970 | $0.00 Strike: $87.74 | $0.00 |
DisclosureSEC source: 0001567619-23-005297 · doc1.xml · derivative · entry 4 Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,970 Underlying: Common Stock · 21,970 shares Expires 2033-03-14 F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:42 UTC |
Mueller BrianEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 2,708 | $87.74 | $237,599.92 |
DisclosureSEC source: 0001567619-23-005297 · doc1.xml · nonDerivative · entry 2 Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,558 Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:42 UTC |
Mueller BrianEVP, Chief Financial Officer
|
GrantCommon Stock | 9,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-005297 · doc1.xml · nonDerivative · entry 1 Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,266 F1 · price: Restricted stock units granted on March 15, 2023. Price not applicable. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:37 UTC |
FUCHS HENRY JPresident, Worldwide R&D
|
GrantStock Option (Right to buy Common Stock) · Derivative | 38,450 | $0.00 Strike: $87.74 | $0.00 |
DisclosureSEC source: 0001567619-23-005295 · doc1.xml · derivative · entry 4 FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,450 Underlying: Common Stock · 38,450 shares Expires 2033-03-14 F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:37 UTC |
FUCHS HENRY JPresident, Worldwide R&D
|
Tax withholdingCommon Stock | 4,799 | $87.74 | $421,064.26 |
DisclosureSEC source: 0001567619-23-005295 · doc1.xml · nonDerivative · entry 2 FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,187 Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:37 UTC |
FUCHS HENRY JPresident, Worldwide R&D
|
GrantCommon Stock | 16,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-005295 · doc1.xml · nonDerivative · entry 1 FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,986 F1 · price: Restricted stock units granted on March 15, 2023. Price not applicable. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:31 UTC |
Davis George EricEVP, Chief Legal Officer
|
GrantStock Option (Right to buy Common Stock) · Derivative | 20,320 | $0.00 Strike: $87.74 | $0.00 |
DisclosureSEC source: 0001567619-23-005292 · doc1.xml · derivative · entry 4 Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,320 Underlying: Common Stock · 20,320 shares Expires 2033-03-14 F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:31 UTC |
Davis George EricEVP, Chief Legal Officer
|
Tax withholdingCommon Stock | 3,025 | $87.74 | $265,413.50 |
DisclosureSEC source: 0001567619-23-005292 · doc1.xml · nonDerivative · entry 2 Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,324 Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:31 UTC |
Davis George EricEVP, Chief Legal Officer
|
GrantCommon Stock | 8,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-005292 · doc1.xml · nonDerivative · entry 1 Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,349 F1 · price: Restricted stock units granted on March 15, 2023. Price not applicable. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:26 UTC |
Burkhart ErinGVP, Chief Accounting Officer
|
GrantStock Option (Right to buy Common Stock) · Derivative | 5,720 | $0.00 Strike: $87.74 | $0.00 |
DisclosureSEC source: 0001567619-23-005287 · doc1.xml · derivative · entry 2 Burkhart Erin · CIK 0001927648 · GVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,720 Underlying: Common Stock · 5,720 shares Expires 2033-03-14 F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:26 UTC |
Burkhart ErinGVP, Chief Accounting Officer
|
GrantCommon Stock | 3,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-005287 · doc1.xml · nonDerivative · entry 1 Burkhart Erin · CIK 0001927648 · GVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,890 F1 · price: Restricted stock units granted on March 15, 2023. Price not applicable. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:16 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
GrantStock Option (Right to buy Common Stock) · Derivative | 23,070 | $0.00 Strike: $87.74 | $0.00 |
DisclosureSEC source: 0001567619-23-005283 · doc1.xml · derivative · entry 4 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,070 Underlying: Common Stock · 23,070 shares Expires 2033-03-14 F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:16 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 3,971 | $87.74 | $348,415.54 |
DisclosureSEC source: 0001567619-23-005283 · doc1.xml · nonDerivative · entry 2 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,996 Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:16 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
GrantCommon Stock | 10,110 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-005283 · doc1.xml · nonDerivative · entry 1 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,967 F1 · price: Restricted stock units granted on March 15, 2023. Price not applicable. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:22 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
GrantStock Option (Right to buy Common Stock) · Derivative | 49,430 | $0.00 Strike: $87.74 | $0.00 |
DisclosureSEC source: 0001567619-23-005285 · doc1.xml · derivative · entry 7 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,430 Underlying: Common Stock · 49,430 shares Expires 2033-03-14 F2 · derivative.exercise_date: Option grant vests 12/36th on March 15, 2024 and 1/36th on the 15th day of each month thereafter. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:22 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 9,437 | $87.74 | $828,002.38 |
DisclosureSEC source: 0001567619-23-005285 · doc1.xml · nonDerivative · entry 2 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,519 Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:22 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
GrantCommon Stock | 36,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-005285 · doc1.xml · nonDerivative · entry 1 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,956 F1 · price: Restricted stock units granted on March 15, 2023. Price not applicable. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:40 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative | 8,000 | $0.00 Strike: $67.81 | $0.00 |
DisclosureSEC source: 0001567619-23-005059 · doc1.xml · derivative · entry 9 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,130 Underlying: Common Stock · 8,000 shares Expires 2023-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · date: Trade made pursuant to a 10b5-1 plan executed on November 17, 2022. F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:40 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
SaleCommon Stock | 8,000 | $90.45 | $723,600.00 |
DisclosureSEC source: 0001567619-23-005059 · doc1.xml · nonDerivative · entry 4 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,856 F2 · date: Trade made pursuant to a 10b5-1 plan executed on November 17, 2022. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:40 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 8,000 | $67.81 | $542,480.00 |
DisclosureSEC source: 0001567619-23-005059 · doc1.xml · nonDerivative · entry 3 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · date: Trade made pursuant to a 10b5-1 plan executed on November 17, 2022. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 23:40 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative | 15,000 | $0.00 Strike: $67.81 | $0.00 |
DisclosureSEC source: 0001567619-23-005059 · doc1.xml · derivative · entry 8 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,130 Underlying: Common Stock · 15,000 shares Expires 2023-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 23:40 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $92.28 | $1,384,200.00 |
DisclosureSEC source: 0001567619-23-005059 · doc1.xml · nonDerivative · entry 2 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,856 F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 23:40 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 15,000 | $67.81 | $1,017,150.00 |
DisclosureSEC source: 0001567619-23-005059 · doc1.xml · nonDerivative · entry 1 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:10 UTC |
Mueller BrianEVP, Chief Financial Officer
|
GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014617 · doc4.xml · nonDerivative · entry 3 Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,636 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F3 · shares: Although earned, the RSUs only vest according to the following schedule: approximately 20% vests on March 16, 2023 and approximately 80% vests on June 29, 2023, subject to the reporting person's continued service through such dates, subject to earlier vesting upon certain events. F5 · shares: Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:10 UTC |
Mueller BrianEVP, Chief Financial Officer
|
GrantCommon Stock | 10,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014617 · doc4.xml · nonDerivative · entry 2 Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,386 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F3 · shares: Although earned, the RSUs only vest according to the following schedule: approximately 20% vests on March 16, 2023 and approximately 80% vests on June 29, 2023, subject to the reporting person's continued service through such dates, subject to earlier vesting upon certain events. F4 · shares: Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:10 UTC |
Mueller BrianEVP, Chief Financial Officer
|
GrantCommon Stock | 12,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014617 · doc4.xml · nonDerivative · entry 1 Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,406 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F2 · shares: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan. F3 · shares: Although earned, the RSUs only vest according to the following schedule: approximately 20% vests on March 16, 2023 and approximately 80% vests on June 29, 2023, subject to the reporting person's continued service through such dates, subject to earlier vesting upon certain events. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:10 UTC |
Davis George EricEVP, Chief Legal Officer
|
GrantCommon Stock | 7,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014614 · doc4.xml · nonDerivative · entry 3 Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,449 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events. F5 · shares: Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:10 UTC |
Davis George EricEVP, Chief Legal Officer
|
GrantCommon Stock | 10,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014614 · doc4.xml · nonDerivative · entry 2 Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,025 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events. F4 · shares: Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:10 UTC |
Davis George EricEVP, Chief Legal Officer
|
GrantCommon Stock | 20,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014614 · doc4.xml · nonDerivative · entry 1 Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,925 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F2 · shares: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan. F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:09 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
GrantCommon Stock | 7,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014609 · doc4.xml · nonDerivative · entry 3 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,857 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events. F5 · shares: Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:09 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
GrantCommon Stock | 10,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014609 · doc4.xml · nonDerivative · entry 2 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,228 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events. F4 · shares: Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:09 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
GrantCommon Stock | 20,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014609 · doc4.xml · nonDerivative · entry 1 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,848 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F2 · shares: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan. F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:08 UTC |
FUCHS HENRY JPresident, Worldwide R&D
|
GrantCommon Stock | 13,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014606 · doc4.xml · nonDerivative · entry 3 FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,146 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events. F5 · shares: Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:08 UTC |
FUCHS HENRY JPresident, Worldwide R&D
|
GrantCommon Stock | 18,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014606 · doc4.xml · nonDerivative · entry 2 FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,754 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events. F4 · shares: Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.